您当前的位置:

Scutellarin

(Synonyms: 野黄芩苷)
目录号: PC13482 纯度: ≥98%
Scutellarin 是从黄芩中分离到的黄酮类物质,在 HCC 细胞中,能够下调 STAT3/Girdin/Akt 信号通路,在破骨细胞中,能够抑制 RANKL 介导的 MAPK/NF-κB 信号通路。
CAS No. :27740-01-8
商品编号 规格 价格 会员价 是否有货 数量
PC13482-20mg 20mg ¥141.25 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Scutellarin
中文别名
野黄芩苷;野黄芩甙;野黄芩苷(灯盏花乙素);灯盏花乙素;高黄芩苷;高黄芩甙;印黄芩苷;黃芹素;元參素;Scutellarin 野黄芩苷 标准品;zzstandard 品牌 野黄芩苷对照品;灯盏花素;灯盏花乙素(野黄芩苷);野黄芩苷( 灯盏花乙素);野黄芩苷,Scutellarin,植物提取物,标准品,对照品;野黄芩苷Scutellarin;野黄芩苷对照品;分析对照品;野黄芩苷( 灯盏花乙素,高黄芩苷,野黄芩甙,高黄芩甙,印黄芩苷,黄芹素,元参素);[ "野黄芩苷", " 灯盏花乙素" ]
英文名称
Scutellarin
英文别名
Scutellarin;7-(beta-d-glucopyranuronosyloxy)-5,6-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one;SCUTELLAREIN 7-O-GLUCURONIDE;(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl;β-D-Glucopyranosiduronicacid,5,6-dihydroxy-2-;4',5,6-Trihydroxy-7-[(β-D-glucopyranuronosyl)oxy]flavone;4',5,6-Trihydroxyflavon-7-yl β-D-glucopyranosiduronic acid;5,6-Dihydroxy-4-oxo-2-(4-hydroxyphenyl)-4H-1-benzopyran-7-yl β-D-glucopyranosiduronic acid;Scutellarein 4'-methyl ether 7-glucuronide;Scutellarein 7-glucuronide;Scutellarein 7-b-D-glucuronide;Scutellarein 7-beta-D-glucuronide;Scutellarin B;SCUTELLARIN(P);Salicin;5,6-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl-β-D-glucopyranosiduronic acid;7-(β-D-Glucopyranuronosyloxy)-5,6-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;Breviscapin Scutellarein-7-O-β-D-glucuronide;Scutellarein 7-;Breviscapin;Scutellarein-7-O-β-D-glucuronide;Scutellarein-7-glucuronide;Breviscapine;Scutellarein-7beta-D-glucuronide;Scutellarein-7beta-D-glucuronoside;Scutellarein-7-O-beta-D-glucuronide;Scutellarein 7-O-beta-D-glucuronide;16IGP0ML9A;beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl;(2S,3S,4S,5R,6S)-6
Cas No.
27740-01-8
分子式
C21H18O12
分子量
462.36
包装储存
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
详情描述
Scutellarin 是从黄芩中分离到的黄酮类物质,在 HCC 细胞中,能够下调 STAT3/Girdin/Akt 信号通路,在破骨细胞中,能够抑制 RANKL 介导的 MAPK/NF-κB 信号通路。
生物活性

Scutellarin, an active flavone isolated from Scutellaria baicalensis, can down-regulates the STAT3/Girdin/Akt signaling in HCC cells, and inhibits RANKL-mediated MAPK and NF-κB signaling pathway in osteoclasts. Scutellarin is active against HIV-1IIIB, HIV-1(74V) and HIV-1KM018 with EC50s of 26 μM, 253 μM and 136 μM, respectively.

性状

Solid

IC50 & Target[1][2]

STAT3

 

HIV-1

 

体外研究(In Vitro)

Scutellarin treatment significantly reduces HepG2 cell viability in a dose-dependent manner, and inhibits migration and invasion of HCC cells 体外研究. Scutellarin treatment significantly reduces STAT3 and Girders of actin filaments (Girdin) expression, STAT3 and Akt phosphorylation in HCC cells. Introduction of STAT3 overexpression restores the scutellarin-downregulated Girdin expression, Akt activation, migration and invasion of HCC cells. Furthermore, induction of Girdin overexpression completely abrogates the inhibition of scutellarin on the Akt phosphorylation, migration and invasion of HCC cells. Scutellarin can inhibit HCC cell metastasis in vivo, and migration and invasion 体外研究 by down-regulating the STAT3/Girdin/Akt signaling. Scutellarin selectively enhances Akt phosphorylation. Scutellarin is a putative therapeutic agent as it has been found to not only suppress microglial activation thus ameliorating neuroinflammation, but also enhance astrocytic reaction. Acutellarin amplifies the astrocytic reaction by upregulating the expression of neurotrophic factors among others thus indicating its neuroprotective role. Remarkably, the effects of scutellarin on reactive astrocytes are mediated by activated microglia supporting a functional "cross-talk" between the two glial types. Scutellarin can suppress RANKL-mediated osteoclastogenesis, the function of osteoclast bone resorption, and the expression levels of osteoclast-specific genes (tartrate-resistant acid phosphatase (TRAP), cathepsin K, c-Fos, NFATc1). Further investigation indicates that Scutellarin can inhibit RANKL-mediated MAPK and NF-κB signaling pathway, including JNK1/2, p38, ERK1/2, and IκBα phosphorylation.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo)

Scutellarin (50 mg/kg/day) significantly mitigates the lung and intrahepatic metastasis of HCC tumors in vivo. The numbers of the lung and intrahepatic metastatic tumors in the scutellarin-treated group are significantly less than that in the controls. The rats treated with Scutellarin display a significant alleviation in neurobehavioral deficits compared to the SAH group. Scutellarin enhanced eNOS expression compared with SAH rats.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

运输条件

Room temperature or refrigerated transportation.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
结构分类
来源
参考文献
溶解度数据
体外研究: 

DMSO : 100 mg/mL (216.28 mM; Need ultrasonic)

配制储备溶液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.1628 mL 10.8141 mL 21.6282 mL
5 mM 0.4326 mL 2.1628 mL 4.3256 mL
10 mM 0.2163 mL 1.0814 mL 2.1628 mL
*

产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,建议在 6 个月内使用,-20°C 储存时,建议在 1 个月内使用。

体内研究:

建议根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都建议先按照 体外研究 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    建议依照次序添加每种溶剂: 0.5% CMC-Na/saline water

    Solubility: 10 mg/mL (21.63 mM); Suspended solution; Need ultrasonic

  • 2.

    建议依照次序添加每种溶剂: 15% Cremophor EL    85% Saline

    Solubility: 5 mg/mL (10.81 mM); Suspended solution; Need ultrasonic

*
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

相关产品

更多
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2